Wealth Enhancement Advisory Services, LLC Veracyte, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 12,953 shares of VCYT stock, worth $313,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,953
Previous 18,199
28.83%
Holding current value
$313,721
Previous $539,000
35.06%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
305Shares Held
79.4MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$189 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$127 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$95.4 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$93.3 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.73B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...